CARDIAC SCIENCE CORPORATION
Manufacturer adverse-event records for CARDIAC SCIENCE CORPORATION come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2006–2026 · mid-book · elevated Death-code · injury-light
Injury-mix signature
CARDIAC SCIENCE CORPORATION is lighter on Injury codes
Injury-coded event_type share is 0.2% (injury-light tercile) beside 1.48% Death-coded (elevated). Volume band: mid.
What the Injury-mix reading shows for CARDIAC SCIENCE CORPORATION
The standout signal for CARDIAC SCIENCE CORPORATION is Injury-mix: 0.2% Injury-coded (injury-light) beside 1.48% Death-coded, on a mid-book footprint.
Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for CARDIAC SCIENCE CORPORATION. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.
Reports span 10 device types, led in this extract by Malfunction at 7,104 (98.2% of event_type total). Peak single-year volume reaches 1,363 reports across 21 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (10)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.